Changsha High-tech Industrial Development Zone (CSHTZ) was established in 1988 and was included within the first batch of national-level high-tech industrial development zones in 1991. It includes the core industrial park of Yuelu Mountain High-tech Park, or Luvalley, which is located on the western bank of Xiangjiang River and on the north side of Mount Lu. The planned area is 140 square kilometers.
CSHTZ’s “one zone, four parks” brought in a total income in 2019 of nearly RMB 500 billion. It ranks 11th among the 168 national high-tech zones in China while the competitiveness of its industrial parks ranks 10th, and the number of national R&D institutions ranks 3rd.
CSHTZ has an advantageous location in China. It is located in west-central Changsha, adjacent to the Hunan Financial Center in the east and Yuelu Mountain University City in the south. It is a natural technological transformation zone. The high-tech zone is 1 km from the comprehensive transportation hub of Xiangjiang New Area, 3 km from the Municipal Party Committee and Municipal Government, 7 km from West High-speed Railway Station, 10 km from Changsha Xianing Port, 10 km from the Changsha Railway Station, 18 km from South High-speed Railway Station, and 28 km from Huanghua International Airport. The Beijing-Guangzhou high-speed railway, the Shanghai-Kunming high-speed railway, and the Chongqing-Hunan high-speed railway intersect in the surrounding area, forming a comprehensive high-speed railway network.
Comprehensive development and steady growth within the biomedical economy
Industries within CSHTZ include chemical pharmacy, traditional Chinese medicine, medical devices, bioengineering, genetic testing, and other fields. The local industry development has formed a relatively distinctive feature: the production of Chinese patent medicines dominates, the medical device industry is developing strongly, the genetic testing industry has great potential, and the reproductive technology industry has unique characteristics. The park has gathered more than 3,400 biomedical companies, including representative companies such as Jiu Zhi Tang Maker, Fangsheng Pharmaceutical, and Sansure Biotech. Meanwhile, there is also the world’s leading research and development technology for high-tech stem cells with the world’s largest embryonic stem cell bank.
- Jiu Zhi Tang Maker
Jiu Zhi Tang Maker is a national key traditional Chinese medicine company and A listed company. Its product line includes OTC, prescription drugs, traditional Chinese medicine, and general health products. Treatment categories cover cardiovascular and cerebrovascular, kidney, blood, women’s health, pediatric health, ENT, and other fields.
- Sansure Biotech
Sansure is one of the leading companies in the Chinese genetic testing industry, with molecular diagnostics and genetic testing as the core technologies. It is a comprehensive solution provider integrating medical diagnostic reagents, medical devices, and third-party medical testing services. The company has developed treatments for infectious disease prevention and cancer prevention and control, women’s health, pediatric health, and chronic disease management encompassing more than 300 products.
Sinocare is the sixth largest blood glucose meter company in the world. The company uses biosensing technology to develop, produce and sell products for rapid detection of chronic diseases. It is one of the most important manufacturers of blood glucose monitoring system products in China. The company is committed to becoming a Chinese diabetes expert and a global blood glucose meter expert. Its products cover blood sugar, blood lipids, glycosylated hemoglobin, uric acid, and other diabetes indicators.
- Hunan Er-kang Pharmaceutical
Er-kang is a Chinese manufacturer of pharmaceutical products. It is also one of the few domestic companies to have the new penicillin antibiotic sulbenicillin sodium API and finish drug registration approval documents.
- Political advantages
CSHTZ fully implements various national, provincial, and municipal preferential policies, as well as establishing and improving policy support systems including industry, talent, innovation, and entrepreneurship. It supports innovation, encourages entrepreneurship, enhances core competitiveness, and encourages companies to grow and develop.
- Talent advantages
Changsha is a densely populated city with many colleges and universities. The number of college students per 10,000 people ranks first in China, and the number of patent applications and authorizations ranks among the top when compared to similar provincial capitals in the country. CSHTZ is close to Yuelu Mountain University Town and relies on the scientific and technological resources from 51 colleges and universities, more than 300 scientific research institutions, and 47 national, provincial, and ministerial key laboratories. The foundation of high-end talent from college students, especially in the disciplines of programming, composite materials, lasers, electronics, traditional Chinese medicine, and chemical engineering, is a boon to the park.
Changsha has 37 post-doctoral research workstations and 40 academician workstations. The gathering of well-known experts and scientific and technological talents from universities has made the high-tech zone a major platform for the transformation of scientific and technological achievements and entrepreneurship.
- Platform advantages
CSHTZ has more than 30 incubators and accelerators sponsored by governments, universities, scientific research institutes, and enterprises; 8 national-level makers’ spaces; and 11 national-level incubators, with a total incubation area of 7 million square meters. This forms a “people’s creative space” with more than 6000 companies incubating. CSHTZ provides venue rental and entrepreneurial services to meet the needs of companies.
National incubators include Changsha Hi-Tech Industry Development Zone Innovation Service Center, Changsha Pioneer Park for Overseas Students in China, Changsha Productivity Promotion Center, Changsha New Technology Entrepreneurship Service Center, Hunan Lugu Technology Incubator Co., Ltd., Changsha Xiangneng Technology Business Incubator Co., Ltd., Hunan University National University Science Park, Changsha Software Park, and others.
There are more than 600 professional technology service institutions for business incubation, R&D and design, technology transfer, investment and financing, and intellectual property rights. There are also more than 600 innovation platforms above the municipal level, including various engineering technology research centers, key laboratories, engineering centers, and business technology centers, including 80 national-level innovation platforms. There are more than 26,000 patents in the park.
- Financial services
Included within China’s first batch of pilot parks to promote the integration of technology and finance, CSHTZ introduced science and technology financial policies covering the entire life cycle of businesses, such as technology credit risk compensation and intellectual property pledge financing. It established the first batch of science and technology sub-branches in the province. There, the and Shanghai Stock Exchange built the province’s first listing workstation, the Shenzhen Stock Exchange built a panoramic online roadshow center, and the Hunan Equity Exchange established a high-tech branch.
CSHTZ attracted investment institutions such as Shenzhen Venture Capital and Fortune Venture Capital. The park has accumulated nearly 900 equity investment institutions and various financial institutions, with a total registered capital of over RMB 130 billion yuan. There are nearly 300 fund and management companies, with a management scale exceeding 100 RMB billion. A multi-level, diversified, and multi-channel investment and financing service system has grown within the development zone.
After rapid development in recent years, Changsha’s biomedical industry has formed a unique industrial development pattern with modern Chinese medicine occupying a dominant position, but also including pharmaceutical products, high-end APIs and preparations, and inspection and testing. In the future, Changsha High-tech Industrial Development Zone is expected to continue to increase investment in biomedicine development policies, mobilize innovation and entrepreneurship, and continue to attract biomedical companies within China and abroad to settle in the high-tech zone. It is poised to build a RMB 100 billion-level industrial cluster.
This article was originally published on the website of our partner, MyBioGate.